Highly Pathogenic H5 Avian Flu Outbreak in the Czech Republic, 8 Birds Infected and 7 Dead, Source of Outbreak Remains a Mystery!
According to the latest information from the World Organization for Animal Health (WOAH), on August 27, 2024, the Czech National Veterinary Authority reported a severe outbreak of H5 highly pathogenic influenza A to WOAH. The outbreak occurred in the Czech Republic, in the town of Krumlov in Southern Bohemia. The outbreak was confirmed on August 26, 2024, but the specific source of the outbreak has not yet been identified or determined.
After a series of clinical observations and laboratory tests, a total of eight birds were found to be suspected to be infected. Of the eight suspected infected birds, seven became ill and eventually died. In order to prevent the further spread of the outbreak, the local veterinary department quickly took measures to cull and properly dispose of the remaining suspected infected bird.
At present, the outbreak is still ongoing, and the Czech National Veterinary Administration said that it will closely monitor the development of the outbreak and promised to submit follow-up reports to WOAH on a weekly basis. This will help the international community better understand the progress of the epidemic and take appropriate prevention and control measures.
2026-10-09
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
China’s 15th Five-Year Plan Sets New Priorities for Pharmaceutical Innovation and Supply Chains
-
2026 Q1 Chemical Giant Earnings: Supply Contraction, Flat Demand, Full-Scale "Defense Priority"
-
GM Crop Area Reaches 216 Million Hectares
-
GM Crop Area Reaches 216 Million Hectares
-
FDA Delays Beetroot Red and Spirulina Color Orders
-
FDA Pushes New Approach to “No Artificial Colors” Claims
-
FDA approves bemotrizinol, a long-used UV filter, for U.S. sunscreens
-
India Proposes New GMP Rules for Clinical Trial and API Manufacturing
-
U.S. and China Reach Consensus on More Favorable Tariff Treatment for $30 Billion of Goods Each Way
-
U.S. Section 232 Pharmaceutical Tariffs Take Effect, With 100% Base Rate on Patented Drugs and APIs
Recommend Reading
-
“全球展会数据”功能上线公告 Announcement on the Launch of the “Global Exhibition Data” Function
-
Colombia Makes Preliminary Ruling in Anti-Dumping Investigation into Chinese DOP Imports
-
Pakistan Launches Successive Anti-dumping Investigations against Chinese Products, Involving Soda Ash, Ibuprofen and Other Raw Materials
-
US Tariff Pressure on Canada Raises Risks for North American Chemical Supply Chains
-
EU Set to Seek Import Quotas on PET, Epoxy Resins and Fibreglass as Trade Curbs Reach Chemicals
-
Double Negative Impact on Costs and Demand—Polyester Staple Fiber Prices Shift Lower in May
-
Narrow Range Consolidation in the Ethanol Market
-
Both Cost and Demand Weaken, PTA Prices Fluctuate and Decline in May
-
In May, China's acetone market shows weak supply and demand, leading to a downward trend
-
MTBE Market Prices Fluctuate and Decline